Intercept Pharmaceuticals Inc ICPT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/09/21 EDT
22.18quote price arrow up+0.01 (+0.05%)
Volume
4,210
Close
22.17quote price arrow down-1.17 (-5.01%)
Volume
1,088,318
52 week range
18.15 - 95.98

...

Loading . . .
  • Open23.02
  • Day High23.37
  • Day Low22.16
  • Prev Close23.34
  • 52 Week High95.98
  • 52 Week High Date05/12/20
  • 52 Week Low18.15
  • 52 Week Low Date03/05/21

Key Stats

  • Market Cap732.05M
  • Shares Out33.02M
  • 10 Day Average Volume1.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.59
  • YTD % Change-10.24

KEY STATS

  • Open23.02
  • Day High23.37
  • Day Low22.16
  • Prev Close23.34
  • 52 Week High95.98
  • 52 Week High Date05/12/20
  • 52 Week Low18.15
  • 52 Week Low Date03/05/21
  • Market Cap732.05M
  • Shares Out33.02M
  • 10 Day Average Volume1.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.59
  • YTD % Change-10.24

RATIOS/PROFITABILITY

  • EPS (TTM)-8.37
  • P/E (TTM)-2.65
  • Fwd P/E (NTM)-4.39
  • EBITDA (MRQ)-215.533M
  • ROE (MRQ)-143,254.90%
  • Revenue (MRQ)312.69M
  • Gross Margin (MRQ)98.30%
  • Net Margin (MRQ)-87.91%
  • Debt To Equity (MRQ)-335.97%

EVENTS

  • Earnings Date05/10/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Intercept Pharmaceuticals Inc

There is no recent news for this security.

Latest From Our Partners

Profile

MORE
Intercept Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. The Company's product candidates have the potential to treat orphan and more prevalent diseases for which there are limited therapeutic solutions. The Company's product candidate, obeticholic acid (OCA), is a bile acid analog, a chemical substance that has a structure based on a...
Paolo Fundaro
Chairman
Jerome Durso
President
Sandip Kapadia CPA
Chief Financial Officer
Christian Weyer M.D. M.A.S.
Executive Vice President
Address
10 Hudson Yards Fl 37
New York, NY
10001-2160
United States

Top Peers

SYMBOLLASTCHG%CHG
AKBA
Akebia Therapeutics Inc
3.06-0.10-3.16%
MDXG
MiMedx Group Inc
12.72+0.64+5.30%
PBYI
Puma Biotechnology Inc
9.33-0.10-1.06%
CLVS
Clovis Oncology Inc
6.23-0.35-5.32%
TVTX
Travere Therapeutics Inc
25.61+0.36+1.43%